NCT00005873View on ClinicalTrials.gov

Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Study Completion Date

April 30, 2004

Conditions
Breast Cancer
Interventions
DRUG

rubitecan

Trial Locations (1)

94568

SuperGen, Incorporated, Dublin

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY